LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Thermo Fisher Scientific
Thermo Fisher Scientific
Unikátní společnost, která se věnuje vědě a pomáhá našim zákazníkům zvyšovat produktivitu a získavat výsledky rychleji. Prostřednictvím našich předních značek - Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific a Unity Lab Services.
Tagy
OMICS
LC/MS
LC/Orbitrap
LC/HRMS
LC/MS/MS
Spotřební materiál
Kolony
LinkedIn Logo

Innovations in protein characterization

ZÁZNAM | Proběhlo Út, 11.2.2025
Tento webinář bude vynikající příležitostí k posílení vašich schopností v oblasti výzkumu a vývoje a k posílení vašich analytických metod kontroly kvality pro charakterizaci bioterapeutik a genových terapií.
Přejít na webinář
Thermo Fisher Scientific: Innovations in protein characterization
Thermo Fisher Scientific: Innovations in protein characterization

Biotherapeutics offer targeted therapies for treating a wide range of diseases with greater specificity and efficacy. However, unlike traditional small-molecule drugs, biotherapeutics are typically larger and more complex, requiring advanced techniques for their production, purification, and characterization.

Therapeutic proteins, first introduced many years ago, have continually advanced in complexity. Since the introduction of monoclonal antibodies, we now have antibody drug conjugates, bispecific antibodies, fragments and fusion proteins, all of which are in various stages of development.

To keep pace with biotherapeutics advances, analytical techniques must also advance.

In this webinar, we will present chromatography findings on:

  • New workflows for intact and peptide mapping characterization of proteins
  • Advanced column chemistries for charge variant analysis with pH and salt gradients
  • Rapid desalting SEC column for high throughput analysis, ADC analysis with HIC and reversed phase chemistries
  • New digestion workflows coupled to a new peptide mapping column for sequence verification and post translation modification analysis

This live webinar will be an excellent opportunity to boost your R&D capabilities and strengthen your QC analytical methods for the characterization of biotherapeutics and gene therapies. Dr. Ken Cook will be presenting and answering your questions live.

With over 20 years of innovation, Thermo Fisher Scientific is a leader in biomolecule separation and characterization, supported by a wealth of published research.

Who should attend?
  • Pharmaceutical and Biotech Researchers: Researchers involved in the development and characterization of biotherapeutics and gene therapies, including those working with therapeutic proteins.
  • Quality Control (QC) Analysts: Analysts responsible for ensuring the quality and consistency of biotherapeutic products, who will benefit from advanced methods in characterization and validation.
  • R&D Managers: Managers who oversee research and development teams working with biotherapeutics, looking to enhance their workflows and methodologies.
Additional Webinars

Take advantage of our growing library of convenient and educational recorded webinars and resources. Visit our webinars page

Presenter: Dr. Ken Cook (Applications Scientists Manager, Thermo Fisher Scientific)

Moved to industry from a University lectureship in Biochemistry, University of Newcastle upon Tyne, following 7 years’ experience in academia. Now with over 35 years’ experience with Thermo Fisher Scientific using a wide range of analytical equipment and software. Publications range from metabolomics, proteomics to large biopharmaceutical drug analysis. Current job title is the European manager for the BioPharma expert support group. This involves the support of Bio-Pharmaceutical applications to characterise protein and oligonucleotide based bio-therapeutics. This involves ongoing collaborations with the Biopharmaceutical industry and academia. Characterization methods of Bio-therapeutics include, monoclonal antibodies, peptides, AAV analytical development, small and large RNA analysis including sequence mapping of mRNA by LC/HRMS.

Thermo Fisher Scientific
LinkedIn Logo
 

Mohlo by Vás zajímat

Overcoming Strong Solvent Effects in the Analysis of Vepdegestrant

Aplikace
| 2026 | Agilent Technologies
Instrumentace
HPLC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

Identification of Double Bond Positions and Relative Acyl Chain Positions in Egg Yolk Phosphatidylcholines Using OAD-TOF System

Aplikace
| 2026 | Shimadzu
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Shimadzu
Zaměření
Potraviny a zemědělství

High Molecular-Weight Polysaccharide Characterization by SEC-MALS Using GTxResolve™ 1000 and 2000 Å SEC Columns

Aplikace
| 2026 | Waters
Instrumentace
GPC/SEC, Spotřební materiál, LC kolony
Výrobce
Waters
Zaměření
Farmaceutická analýza, Potraviny a zemědělství

Development and Optimization for a Comprehensive LC/MS/MS Method for the Detection of 74 PFAS Compounds

Aplikace
| 2026 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Potraviny a zemědělství

PFAS in Biota: Risk Context & Robust Analytical Solutions

Ostatní
| 2026 | ALS Europe
Instrumentace
Laboratorní rozbory, LC/MS, LC/MS/MS
Výrobce
Zaměření
Životní prostředí
Další projekty
GCMS
ICPMS
Sledujte nás
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.